Establishing the benefit of statins in low-to-moderate—risk primary prevention: The Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)  A.M. Gotto Jr.  Atherosclerosis Supplements  Volume 8, Issue 2, Pages 3-8 (August 2007) DOI: 10.1016/j.atherosclerosissup.2007.02.002 Copyright © 2007 Terms and Conditions

Fig. 1 Baseline lipids parameters in AFCAPS/TexCAPS, Lipids Research Clinics (LRC-CCP), Helsinki Heart Study (HHS), and WOSCOPS. Atherosclerosis Supplements 2007 8, 3-8DOI: (10.1016/j.atherosclerosissup.2007.02.002) Copyright © 2007 Terms and Conditions

Fig. 2 AFCAPS/TexCAPS: percent changes of lipids parameters from baseline to year 1. Reproduced with permission from ref. [1]. Atherosclerosis Supplements 2007 8, 3-8DOI: (10.1016/j.atherosclerosissup.2007.02.002) Copyright © 2007 Terms and Conditions

Fig. 3 AFCAPS/TexCAPS: first acute major coronary event. Adapted with permission from ref. [1]. Atherosclerosis Supplements 2007 8, 3-8DOI: (10.1016/j.atherosclerosissup.2007.02.002) Copyright © 2007 Terms and Conditions

Fig. 4 Secondary endpoint analyses. Adapted with permission from ref. [1]. Atherosclerosis Supplements 2007 8, 3-8DOI: (10.1016/j.atherosclerosissup.2007.02.002) Copyright © 2007 Terms and Conditions

Fig. 5 Relation of acute major coronary events with baseline and year 1 LDL-C and ApoB adjusted for age, sex, marital status, hypertension, smoking, and family history. Adapted with permission from ref. [5]. Atherosclerosis Supplements 2007 8, 3-8DOI: (10.1016/j.atherosclerosissup.2007.02.002) Copyright © 2007 Terms and Conditions